酪氨酸蛋白激酶SYK相关基因特征在基线免疫细胞中与黑色素瘤辅助免疫治疗诱发的免疫相关不良事件的关系（补充图S6）

Monson等人（周二）研究了这个问题。

www.synapsesocial.com/papers/68e56226e2b3180350efef33 — DOI: https://doi.org/10.1158/1078-0432.27142333

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Supplementary Figure S7 from Tyrosine Protein Kinase SYK-Related Gene Signature in Baseline Immune Cells Associated with Adjuvant Immunotherapy–Induced Immune-Related Adverse Events in Melanoma· 2024
2. Supplementary Figure S5 from Tyrosine Protein Kinase SYK-Related Gene Signature in Baseline Immune Cells Associated with Adjuvant Immunotherapy–Induced Immune-Related Adverse Events in Melanoma· 2024
3. Supplementary Figure S1 from Tyrosine Protein Kinase SYK-Related Gene Signature in Baseline Immune Cells Associated with Adjuvant Immunotherapy–Induced Immune-Related Adverse Events in Melanoma· 2024
4. Supplementary Figure S3 from Tyrosine Protein Kinase SYK-Related Gene Signature in Baseline Immune Cells Associated with Adjuvant Immunotherapy–Induced Immune-Related Adverse Events in Melanoma· 2024
5. Supplementary Figure S4 from Tyrosine Protein Kinase SYK-Related Gene Signature in Baseline Immune Cells Associated with Adjuvant Immunotherapy–Induced Immune-Related Adverse Events in Melanoma· 2024